Condition
Acute Lymphoblastic Leukemia With Failed Remission clinical trials and research
As of November 12, 2026, Find a Trial lists 5 Acute Lymphoblastic Leukemia With Failed Remission clinical trials that are recruiting, at sites in 5 countries (most in Jordan (1), China (1), United States (1)). By phase: Phase 1 (2), Phase 2 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 5Clinical trials
- 5Countries
Newest Acute Lymphoblastic Leukemia With Failed Remission clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| Point-of-care MB-CART19.1 CAR-T therapy for relapsed or refractory B‑ALL | — | Amman | Recruiting | Jan 27, 2026 |
| CAR-T cell therapy for adults with relapsed or refractory leukemia and lymphoma | Phase 1 | Nanchang, Jiangxi and 1 other locations | Recruiting | Jun 6, 2024 |
| Bortezomib treatment for relapsed or refractory acute lymphoblastic leukemia | Phase 2 | São Paulo, São Paulo | Recruiting | Sep 13, 2023 |
| Understanding why CAR T cells don't last in leukemia treatment | — | London and 2 other locations | Recruiting | Apr 12, 2023 |
| Venetoclax treatment for high-risk blood cancers in young patients | Phase 1 | San Francisco, California and 4 other locations | Recruiting | Mar 23, 2022 |
All recruiting trials (5)
-
Point-of-care MB-CART19.1 CAR-T therapy for relapsed or refractory B‑ALL
This will test whether autologous, point-of-care manufactured CD19-directed CAR-T cells (MB-CART19.1) can treat children and adults with relapsed or refractory B‑cell acute lymphoblastic leukemia.
-
CAR-T cell therapy for adults with relapsed or refractory leukemia and lymphoma
This study is testing a new CAR-T cell therapy to see if it can help adults with tough-to-treat leukemia or lymphoma feel better and fight their cancer.
-
Bortezomib treatment for relapsed or refractory acute lymphoblastic leukemia
This study is testing if a new treatment using bortezomib can help adults with hard-to-treat acute lymphoblastic leukemia feel better and prepare for a stem cell transplant.
-
Understanding why CAR T cells don't last in leukemia treatment
This study looks at kids and young adults with leukemia to see why CAR T cells don't stick around long enough after treatment and what might help them last longer.
-
Venetoclax treatment for high-risk blood cancers in young patients
This study is testing a new combination of a drug called venetoclax with chemotherapy to see if it helps young patients with high-risk blood cancers feel better while keeping side effects low.
Related topics
Quick answers
How many Acute Lymphoblastic Leukemia With Failed Remission clinical trials are recruiting right now?
5, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 5 countries. The most sites are in Jordan (1 trial), China (1 trial), United States (1 trial), United Kingdom (1 trial), Brazil (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 1: 2, Phase 2: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.